Pharmaceutical Market Europe • March 2025 • 36
APPOINTMENTS
Pfizer
Patrizia Cavazzoni
Pfizer has appointed Patrizia Cavazzoni as chief medical officer, executive vice president. Cavazzoni holds more than 25 years of experience in clinical development, pharmacovigilance, clinical operations, regulatory affairs, safety risk management, pharmacovigilance, epidemiology and research and development strategy. She most recently served as director of the Center for Drug Evaluation and Research at the US Food and Drug Administration, during which time she worked to ensure the availability of safe and effective medicines and led the regulatory and policy decisions on prescription and over-the-counter medicines. Prior to this, Cavazzoni held several senior executive positions over nearly two decades at pharmaceutical companies including Pfizer, as well as Eli Lilly and Sanofi. She succeeds Aida Habtezion.
Merck KGaA
Jean-Charles Wirth
Merck KGaA has appointed Jean-Charles Wirth as chief executive officer for life sciences. Wirth currently serves as global head of Merck's science and lab solutions business unit. Prior to this, he held roles of increasing responsibility at the company, including head of its applied solutions business unit and chief financial officer for life sciences.
Merck KGaA
Danny Bar-Zohar
Merck KGaA has appointed Danny Bar-Zohar as chief executive officer for healthcare. Bar-Zohar has most recently been serving as global head of research and development and chief medical officer of Merck’s healthcare business sector, after joining the company as global head of development. Prior to this, he held roles at Novartis and Teva Pharmaceuticals.
CNX Therapeutics
Peter Butterfield
CNX Therapeutics has appointed Peter Butterfield as chief operating officer. Butterfield brings extensive pharmaceutical and consumer healthcare experience to the position, having most recently served as chief executive officer of Alliance Pharmaceuticals. He held roles of increasing responsibility at Alliance after joining the company almost 15 years ago.
Ventus Therapeutics
Mona Kotecha
Ventus Therapeutics has appointed Mona Kotecha as chief medical officer. Kotecha brings 20 years of experience to the role, which she takes on after serving as chief medical officer of ExploR&D, a division of Eli Lilly’s Catalyze360. Prior to this, she led clinical development for pain and psychiatry at Biogen and held positions at Gilead Sciences.
Pfizer
Jeffrey Legos
Pfizer has appointed Jeffrey Legos as chief oncology officer. Legos joins the company from Novartis, where he has most recently been serving as executive vice president and global head of oncology and haematology development. Prior to joining Novartis around a decade ago, Legos was vice president and global medicines development leader in oncology at GSK.
Ottimo Pharma
Katherine Bell-McGuinn
Ottimo Pharma has appointed Katherine Bell-McGuinn as senior vice president of clinical development. Bell-McGuinn holds decades of leadership experience in oncology clinical development. She most recently served as chief medical officer at 858 Therapeutics. Prior to this, she was vice president, head of oncology early development at AbbVie.
Ottimo Pharma
Robert Tighe
Ottimo Pharma has appointed Robert Tighe as senior vice president of preclinical and translational sciences. Tighe has more than two decades of experience in preclinical and translational cancer therapy development. He was most recently chief scientific officer at Ankyra Therapeutics and previously held senior positions at TCR2 Therapeutics and Compass Therapeutics.
UCB
Stevan Shaw
UCB has appointed Stevan Shaw as head of UK Research. Shaw brings extensive industry experience to his latest role. He originally joined UCB over 30 years ago and his career has focused on discovering and developing therapeutics for severe immunological diseases. He most recently led the company’s UK research team in inflammatory dermatology and rheumatology.
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services